Saturna Capital Corp Charles River Laboratories International, Inc. Transaction History

Saturna Capital Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$164.52 - $238.84 $6,909 - $10,031	-42 Reduced 1.03%	4,017 $949,000
Q2 2023 Aug 04, 2023	BUY	$183.71 - $210.25 $18,371 - $21,025	100 Added 2.53%	4,059 $853,000
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $69,847 - $94,610	364 Added 10.13%	3,959 $799,000
Q1 2020 May 14, 2020	BUY	$98.9 - $178.34 $118,680 - $214,008	1,200 Added 50.1%	3,595 $454,000
Q2 2019 Jul 31, 2019	BUY	$123.4 - $148.55 $111,060 - $133,695	900 Added 60.2%	2,395 $340,000
Q1 2019 May 15, 2019	BUY	$104.82 - $146.73 $156,705 - $219,361	1,495 New	1,495 $217,000
Q4 2018 Feb 08, 2019	SELL	$105.09 - $137.23 $157,109 - $205,158	-1,495 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$112.11 - $134.54 $167,604 - $201,137	1,495 New	1,495 $201,000

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Saturna Capital Corp with notifications on news.